Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 141 publications
Phase III randomized studies of mevrometostat and enzalutamide in metastatic prostate cancer (MEVPRO-1 and MEVPRO-2): trial protocols.
Journal: Future oncology (London, England)
Published: May 11, 2026
SPEN inactivation drives resistance to androgen receptor pathway inhibitors in metastatic prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 13, 2026
Piggybacking Towards Progress for CAR-T Cell Therapy in Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 02, 2026
PSMA PET/CT-derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617.
Journal: Radiology
Published: March 31, 2026
Clinical Trial Protocol for LPS-Boost: Intensified [177Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 08, 2026
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer.
Journal: Molecular cancer research : MCR
Published: January 14, 2026
Molecular landscape of prostate cancers with clival metastases.
Journal: The oncologist
Published: December 22, 2025
A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer.
Journal: The oncologist
Published: December 22, 2025
Molecular subtypes of metastatic prostate cancer: from pathophysiology to diagnosis.
Journal: Histopathology
Published: December 12, 2025
Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer.
Journal: JCO precision oncology
Published: December 05, 2025
Beyond androgen deprivation therapy: Next-generation hormonal therapies and emerging combination approaches in advanced prostate cancer.
Journal: Urologic oncology
Published: December 03, 2025
Last Updated: 09/26/2026